Home/Supreme Court/Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S

Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S

179 L. Ed. 2d 653, 131 S. Ct. 1808, 563 U.S. 902, 2011 U.S. LEXIS 2434, 79 U.S.L.W. 3552
Procedural entryThis page is a short order in Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S. Read the opinion of the Court — 132 S. Ct. 1670 →
Supreme Court of the United States·Decided March 28, 2011·No. No. 10-844·Published

Opinion

The Acting Solicitor General is invited to file a brief in this case expressing the views of the United States.

Free access — add to your briefcase to read the full text and ask questions with AI

Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S, 179 L. Ed. 2d 653, 131 S. Ct. 1808, 563 U.S. 902, 2011 U.S. LEXIS 2434, 79 U.S.L.W. 3552 (U.S. 2011).

179 L. Ed. 2d 653 (Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.